Development and Validation of Stability Indicating RP-HPLC Method for Estimation of Larotrectinib in its Formulations

被引:1
|
作者
Fatima, Mahreen [1 ]
Koneru, Anupama [2 ]
Khan, M. Mushraff Ali [3 ]
Varanasi, Murali Balaram [1 ]
Syed, Imam Pasha [1 ]
机构
[1] Sultan Ul Uloom Coll Pharm, Dept Pharmaceut Qual Assurance, 8-2-249,Rd 3, Hyderabad 500034, Telangana, India
[2] Sultan Ul Uloom Coll Pharm, Dept Pharmacol, 8-2-249,Rd 3, Hyderabad 500034, Telangana, India
[3] Sultan Ul Uloom Coll Pharm, Dept Pharmaceut, 8-2-249,Rd 3, Hyderabad 500034, Telangana, India
关键词
HPLC; Larotrectinib; Method development; ICH Guidelines; FUSION;
D O I
10.13005/ojc/360216
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A stability indicating HPLC method for the quantification of Larotrectinib in capsule form was developed and validated as per the ICH guidelines. Separation and quantification of Larotrectinib was carried out on column Sunsil C-18 using mobile phase as KH2PO4 and methanol in 1:1 ratio. Larotrectinib was eluted at 3.432 minutes. Linearity was observed in between 50-150 mu g/ml. LOD and LOO were found to be 0.065 mu g/ml and 0.217 mu g/ml respectively. % RSD for the precision of the method was found to be 0.115. Accuracy was well within the regulated limit that is 100.13% and the recovery was found to be to 100.47%. Forced degradation analysis was carried out on Larotrectinib which established stability indicating power of the developed method.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [1] Development and Validation of Stability Indicating RP-HPLC Method for the Estimation of Cinacalcet Hydrochloride in Bulk and Their Formulations
    Rao, Nagasarapu Mallikharjuna
    Sankar, Dannana Gowri
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2020, 10 (06): : 6610 - 6618
  • [2] STABILITY INDICATING METHOD DEVELOPMENT OF RIMONABANT AND IT's VALIDATION BY RP-HPLC AND HPTLC METHOD
    Srilatha, Bollepaka
    Illendula, Santhosh
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (06): : 5602 - 5610
  • [4] A New Stability Indicating Rp-Hplc Method Development And Validation For Estimation Of Baloxavir Marboxil In Pharmaceutical Dosage Form
    Ashira, T., V
    Praseetha, K.
    Indukala, P. C.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 970 - 983
  • [5] Development and Validation of a Stability-Indicating Related Substances RP-HPLC Method for Anagliptin and its Degradation Products
    Rajendra S. Chavan
    Abdul Ahad
    Rajendra Phase
    Qasim Ullah
    Sabreena Yameen
    Pathan Mohd Arif
    Pharmaceutical Chemistry Journal, 2023, 57 : 1314 - 1322
  • [6] Development and Validation of a Stability-Indicating Related Substances RP-HPLC Method for Anagliptin and its Degradation Products
    Chavan, Rajendra S.
    Ahad, Abdul
    Phase, Rajendra
    Ullah, Qasim
    Yameen, Sabreena
    Arif, Pathan Mohd
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2023, 57 (08) : 1314 - 1322
  • [7] Stability Indicating Method Development and Validation for the Estimation of Rotigotine by RP-HPLC in Bulk and Pharmaceutical Dosage Form
    Swarupa, P. Geetha
    Krishna, D. Radha
    Prasad, K. R. S.
    Babu, K. Suresh
    ORIENTAL JOURNAL OF CHEMISTRY, 2015, 31 (04) : 2499 - 2505
  • [8] Method Development and Validation of Valsartan by Using Stability-Indicating RP-HPLC Method
    Penumuru, Srujana
    Tenkayala, Shobha Rani
    Ranga, Gangadhara
    Bandi, Ramachandra
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2024, 12 (04) : 326 - 337
  • [9] Development and Validation of Stability Indicating Assay for Simultaneous Determination of Bupivacaine and Meloxicam in Bulk and Pharmaceutical Formulations by Using Rp-Hplc Method
    Seles, K. Stefi
    Padmavathi, Sakinala
    Rahaman, Shaik Abdul
    ShabanaAzmi
    ShinyGrace, D.
    AmreenSahana, Mohamad
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2022, 12 (06): : 117 - 131
  • [10] Stability Indicating Method Development and Validation for Valacyclovir in Bulk and Tablet Dosage Form by Rp-Hplc
    Digge, Vaijinath G.
    Patil, S. S.
    Panchal, C. V.
    JOURNAL OF COMPLEMENTARY MEDICINE RESEARCH, 2021, 12 (04): : 30 - 38